Efficacy and safety of once daily versus intermittent dosing of tobramycin in rabbits with acute pyelonephritis

Scand J Infect Dis. 1988;20(2):205-12. doi: 10.3109/00365548809032439.

Abstract

Unilateral pyelonephritis was induced in 50 rabbits by injecting Escherichia coli (minimum inhibitory concentration of tobramycin 0.25 mg/l) into the left kidney and by obstructing the ureter temporarily. Tobramycin treatment (daily dose 10 mg/kg) was started 4 days after surgery, either in a single daily dose or in 3 divided doses at 8 h intervals, for 2, 3, 5, 7 or 10 days. Comparison of bacteriology, renal morphology, and renal functions (BUN, serum creatinine, alanine aminopeptidase, N-acetyl-beta-D-glucosaminidase, cathepsin B, sphingomyelinase) suggests better efficacy and renal tolerance of the single daily dose regimen in the treatment of experimental acute pyelonephritis.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylglucosaminidase / metabolism
  • Aminopeptidases / metabolism
  • Animals
  • CD13 Antigens
  • Cathepsin B / metabolism
  • Drug Administration Schedule
  • Kidney / enzymology
  • Kidney / pathology
  • Kidney / physiopathology
  • Male
  • Pyelonephritis / drug therapy*
  • Pyelonephritis / pathology
  • Pyelonephritis / physiopathology
  • Rabbits
  • Sphingomyelin Phosphodiesterase / metabolism
  • Tobramycin / administration & dosage*
  • Tobramycin / therapeutic use

Substances

  • Sphingomyelin Phosphodiesterase
  • Acetylglucosaminidase
  • Aminopeptidases
  • CD13 Antigens
  • Cathepsin B
  • Tobramycin